Abstract
Chimeric antigen receptor (CAR) transduced T cells have significantly improved cancer immunotherapy. Similarly, engineering regulatory T cells (Treg) with specific receptors to endow specificity and increase efficacy of Tregs holds great promise for therapy of a variety of adverse immune responses. In this review, we focus on our approaches using retroviral transduction of specific T-cell receptors, single chain variable fragments (scFv) or antigen in models of monogenic diseases, autoimmunity and allergy. The advantages of each of these for different targets diseases are discussed as well as their potential for clinical translation.
Funder
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Multiple Sclerosis Society
Pfizer
Subject
Immunology,Immunology and Allergy
Reference41 articles.
1. Infectious Immunological Tolerance;Gershon;Immunol,1971
2. Study on Cellular Events in Postthymectomy Autoimmune Oophoritis in Mice. I. Requirement of Lyt-1 Effector Cells for Oocytes Damage After Adoptive Transfer;Sakaguchi;J Exp Med,1982
3. The Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) Is Caused by Mutations of FOXP3;Bennett;Nat Genet,2001
4. FOXP3 and Scurfy: How It All Began;Ramsdell;Nat Rev Immunol,2014
5. A Molecular Map of the Immune Response Region From the Major Histocompatibility Complex of the Mouse;Steinmetz;Nature,1982
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献